Develops oral small-molecule drugs targeting neuroinflammation in CNS diseases by inhibiting microglia-driven inflammation.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
NeuroTherapia is a clinical-stage, privately held biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system (CNS), including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and other CNS conditions. There is an emerging consensus that neuroinflammation plays a significant role in CNS disease. NeuroTherapia is developing therapeutics that inhibit microglia cells, which are known to express proteins that drive inflammation in the CNS, without affecting the clearance of toxic beta amyloid.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
NeuroTherapia Management Team
Investors
Alzheimer’s Drug Discovery Foundation (ADDF)
Brain Trust Accelerator Fund
Cleveland Clinic
CRUINT
Dolby Family Ventures LP
Foundation for a Better World
NeuroTherapia Valuations & Financials
View real-time NPM data on NeuroTherapia stock including daily NeuroTherapia stock price estimates, valuation history, and historical share price information. Access NeuroTherapia financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track NeuroTherapia pricing across six independent market signals. Looking for private company due diligence data sources on NeuroTherapia? Get in touch to learn more.
Similar Companies
like NeuroTherapia
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
NetBox Labs
Enterprise Software
Automating that enables infrastructure teams to manage network topology and configuration through integrated observability and security tools.
Enteligent
Climate & Sustainability
Enables affordable, efficient daytime EV charging and solar optimization with intelligent monitoring and rapid shutdown safety features.
ValGenesis
Healthcare & Life Sciences
Automates validation lifecycle that streamlines compliance, traceability and risk management across all regulated system and process validation.
Builder Prime
Enterprise Software
Delivers a platform that helps contractors manage projects, clients, and finances through integrated business tools.
Hyphen
AI & Machine Learning
Builds robotic meal assembly systems and software to streamline kitchen operations, reduce waste, and increase throughput.
Gloat
AI & Machine Learning
Delivers an AI-powered platform that integrates AI into daily workflows to boost collaboration, productivity, and workforce readiness.
Knit
AI & Machine Learning
Offers a platform that supports personalized financial benefits for young employees through tools aligned with modern savings and investing needs.
Alsym Energy
Climate & Sustainability
Develops nonflammable, non-lithium rechargeable batteries as a safer alternative to lithium-ion.
FAQ
We have answers
NeuroTherapia stock does not trade on public stock exchanges. NeuroTherapia stock is considered a private security and you need to be an accredited investor to trade shares. To invest in NeuroTherapia stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
NeuroTherapia Stock does not trade on public stock exchanges. In order to sell NeuroTherapia shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
NeuroTherapia does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view NeuroTherapia share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for NeuroTherapia stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell NeuroTherapia stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in NeuroTherapia stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
NeuroTherapia is a private company and has not had an IPO. There is currently no NeuroTherapia IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to NeuroTherapia IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
